English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52842294    線上人數 :  709
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yen cj"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 46-95 / 99 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國家衛生研究院 2017-08-29 Investigating the association between alcohol and risk of head and neck cancer in Taiwan Huang, CC;Hsiao, JR;Lee, WT;Lee, YC;Ou, CY;Chang, CC;Lu, YC;Huang, JS;Wong, TY;Chen, KC;Tsai, ST;Fang, SY;Wu, JL;Wu, YH;Hsueh, WT;Yen, CJ;Wu, SY;Chang, JY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS
國家衛生研究院 2017-06-15 Hydrogen gas protects IP3Rs by reducing disulfide bridges in human keratinocytes under oxidative stress Wu, CY;Hsu, WL;Tsai, MH;Liang, JL;Lu, JH;Yen, CJ;Yu, HS;Noda, M;Lu, CY;Chen, CH;Yan, SJ;Yoshioka, T
國家衛生研究院 2017-05 A phase I dose escalation study of SCBO1A, a micro tubular inhibitor with vascular disrupting activity, in patients with advanced solid tumors refractory to standard therapy Chiang, NJ;Shiah, HS;Lin, CC;Yen, CJ;Tsai, HJ;Wu, SY;Su, WC;Chang, KY;Chen, LT
國家衛生研究院 2017-04-21 Regular recreational physical activity and risk of head and neck cancer Lin, CL;Lee, WT;Ou, CY;Hsiao, JR;Huang, CC;Huang, JS;Wong, TY;Chen, KC;Tsai, ST;Fang, SY;Huang, TT;Wu, JL;Wu, YH;Hsueh, WT;Yen, CJ;Lai, YH;Liao, HC;Wu, SY;Yang, MW;Lin, FC;Chang, JY;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS
國家衛生研究院 2017-02 A phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer Chiang, NJ;Chen, JS;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Shan, YS;Chen, LT
國家衛生研究院 2017-01 Inhibition of the EGFR/STAT3/CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder Wang, WJ;Li, CF;Chu, YY;Wang, YH;Hour, TC;Yen, CJ;Chang, WC;Wang, JM
國家衛生研究院 2016-12 Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells Chan, TS;Hsu, CC;Pai, VC;Liao, WY;Huang, SS;Tan, KT;Yen, CJ;Hsu, SC;Chen, WY;Shan, YS;Li, CR;Lee, MT;Jiang, KY;Chu, JM;Lien, GS;Weaver, VM;Tsai, KK
國家衛生研究院 2016-11 Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma Chen, HA;Kuo, TC;Tseng, CF;Ma, JT;Yang, ST;Yen, CJ;Yang, CY;Sung, SY;Su, JL
國家衛生研究院 2016-10-25 A comprehensive analysis on the association between tobacco-free Betel Quid and risk of Head and Neck Cancer in Taiwanese men Wu, YH;Yen, CJ;Hsiao, JR;Ou, CY;Huang, JS;Wong, TY;Tsai, ST;Huang, CC;Lee, WT;Chen, KC;Fang, SY;Wu, JL;Hsueh, WT;Lin, FC;Yang, MW;Chang, JY;Liao, HC;Wu, SY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS
國家衛生研究院 2016-09 Allergy symptoms, serum total immunoglobulin E, and risk of head and neck cancer Liao, HC;Wu, SY;Ou, CY;Hsiao, JR;Huang, JS;Tsai, ST;Huang, CC;Wong, TY;Lee, WT;Chen, KC;Fang, SY;Wu, JL;Huang, TT;Wu, YH;Hsueh, WT;Yen, CJ;Yang, MW;Lin, FC;Lai, YH;Chang, JY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS
國家衛生研究院 2016-05 Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma Tsai, HW;Lin, YJ;Wu, HC;Chang, TT;Wu, IC;Cheng, PN;Yen, CJ;Chan, SH;Huang, W;Su, IJ
國家衛生研究院 2016-05 Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC) Abou-Alfa, GK;Qin, SK;Ryoo, BY;Lu, SN;Yen, CJ;Feng, YH;Lim, HY;Izzo, F;Colombo, M;Sarker, D;Bolondi, L;Vaccaro, GM;Harris, WP;Chen, ZD;Hubner, R;Meyer, T;Bomalaski, JS;Lin, CC;Chao, Y;Chen, LT
國家衛生研究院 2015-11 HMBD and 5-AzadC combination reverses tumor suppressor CCAAT/enhancer binding protein delta to strengthen the death of liver cancer cells Wang, JM;Li, CF;Tsai, HH;Ko, CY;Pan, YC;Yen, CJ;Lai, HY;Yuh, CH;Wu, WC
國家衛生研究院 2015-07 Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis Hsieh, YH;Chang, YY;Su, IJ;Yen, CJ;Liu, YR;Liu, RJ;Hsieh, WC;Tsai, HW;Wang, LHC;Huang, WY
國家衛生研究院 2015-07 Alcohol drinking obliterates the inverse association between serum retinol and risk of head and neck cancer Chen, KC;Hsueh, WT;Ou, CY;Huang, CC;Lee, WT;Fang, SY;Tsai, ST;Huang, JS;Wong, TY;Wu, JL;Yen, CJ;Wu, YH;Lin, FC;Yang, MW;Chang, JY;Liao, HC;Wu, SY;Hsiao, JR;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chen, YS;Chang, JS
國家衛生研究院 2015-05 A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT
國家衛生研究院 2015-03 Genetic polymorphisms in the prostaglandin pathway genes and risk of head and neck cancer Lee, WT;Huang, CC;Chen, KC;Wong, TY;Ou, CY;Tsai, ST;Yen, CJ;Fang, SY;Lo, HI;Wu, YH;Hsueh, WT;Yang, MW;Lin, FC;Hsiao, JR;Huang, JS;Chang, JY;Chang, KY;Wu, SY;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS
國家衛生研究院 2014-11 The interplay between alcohol consumption, oral hygiene, ALDH2 and ADH1B in the risk of head and neck cancer Tsai, ST;Wong, TY;Ou, CY;Fang, SY;Chen, KC;Hsiao, JR;Huang, CC;Lee, WT;Lo, HI;Huang, JS;Wu, JL;Yen, CJ;Hsueh, WT;Wu, YH;Yang, MW;Lin, FC;Chang, JY;Chang, KY;Wu, SY;Liao, HC;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS
國立成功大學 2014-11 Results of a phase I, open-label, multicentre study to assess the safety, tolerability, pharmacokinetics and preliminary antitumour activity of AZD9150 in patients with advanced/metastatic hepatocellular carcinoma Kang, Y. K.; Ryoo, BY; Kim, TY; Lee, KH; Lim, HY; Lee, SJ; Ikeda, M; Okusaka, T; Nadano, S; Lin, CC; Poon, TP; Yen, CJ; McCoon, P; Neumann, F; Vishwantahan, K; DuPont; Lyne, P
國家衛生研究院 2014-10-24 Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5year follow-up Wu, SY;Wu, YH;Yang, MW;Hsueh, WT;Hsiao, JR;Tsai, ST;Chang, KY;Chang, J;Yen, CJ
國家衛生研究院 2014-07 Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of High-Dose 5-Fluorouracil and Leucovorin as first-line treatment for patients with advanced gastric cancer Shen, YC;Li, CP;Yen, CJ;Hsu, C;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Yeh, KH;Cheng, AL
中國醫藥大學 2014-06 Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma (Wu CS);(Lee TY);鄒瑞煌(Ruey-Hwang Chou);(Yen CJ);黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)*
國家衛生研究院 2014-05-05 Tea consumption and risk of head and neck cancer Huang, CC;Lee, WT;Tsai, ST;Ou, CY;Lo, HI;Wong, TY;Fang, SY;Chen, KC;Huang, JS;Wu, JL;Yen, CJ;Hsueh, WT;Wu, YH;Yang, MW;Lin, FC;Chang, JY;Chang, KY;Wu, SY;Hsiao, JR;Lin, CL;Wang, YH;Weng, YL;Yang, HC;Chang, JS
亞洲大學 2014-04 Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Wu, CS;Wu, CS;Yen, CJ;Yen, CJ;鄒瑞煌;Chou, Ruey-Hwang;Chen, JN;Chen, JN;Huang, WC;Huang, WC;Wu, CY;Wu, CY;余永倫
中國醫藥大學 2014-04 Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2–induced Globo H expression 吳承修;(Yen CJ);鄒瑞煌(Ruey-Hwang Chou);陳佳妮;黃偉謙(Wei-Chien Huang);(Wu CY);余永倫(Yung-Luen Yu)*
國家衛生研究院 2013-10 Investigating the association between oral hygiene and head and neck cancer Chang, JS;Lo, HI;Wong, TY;Huang, CC;Lee, WT;Tsai, ST;Chen, KC;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, KY;Chang, JY;Ou, CY;Wang, YH;Weng, YL;Yang, HC;Wang, FT;Lin, CL;Huang, JS;Hsiao, JR
國家衛生研究院 2013-06-27 Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;Chang, JY
國家衛生研究院 2013-06 SUMOylated CPAP is required for IKK-mediated NF-kappaB activation and enhances HBx-induced NF-kappaB signaling in HCC Yang, ST;Yen, CJ;Lai, CH;Lin, YJ;Chang, KC;Lee, JC;Liu, YW;Chang-Liao, PY;Hsu, LS;Chang, WC;Hung, WC;Tang, TK;Liu, YW;Hung, LY
國家衛生研究院 2013-06 Oral hygiene and risk of head and neck cancer Chang, J;Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Wang, YH;Weng, YL;Yang, HC;Lin, CL;Wang, FT
國家衛生研究院 2013-04 EGFR variant III act as the major determinant factors in the EGFR/PI3K/AKT pathway for the survival outcome of oral cancer patients Chang, KY;Tsai, SY;Chen, SH;Tsou, HH;Yen, CJ;Tang, CK;Yen, CY;Chang, JY
國家衛生研究院 2013-02-01 Allergies and risk of head and neck cancer: An original study plus meta-analysis Hsiao, JR;Ou, CY;Lo, HI;Huang, CC;Lee, WT;Huang, JS;Chen, KC;Wong, TY;Tsai, ST;Yen, CJ;Wu, YH;Hsueh, WT;Yang, MW;Wu, SY;Chang, JY;Chang, KY;Lin, CL;Wang, FT;Wang, YH;Weng, YL;Yang, HC;Chang, JS
國家衛生研究院 2013-02 Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients Hsieh, YH;Su, IJ;Yen, CJ;Tsai, TF;Tsai, HW;Tsai, HN;Huang, YJ;Chen, YY;Ai, YL;Kao, LY;Hsieh, WC;Wu, HC;Huang, W
臺北醫學大學 2013 Dissecting the EGFR-P13K-AKT pathway in oral cancer highlights the roles of the EGFR variant III and its clinical relevance Chang, KY;Tsia, SY;Chen, SH;Tsou, HH;Yen, CJ;Liu, KJ;Fang, HL;Wu, HC;Chuang, BF;Chou, SW;Tang, CK;Liu, SY;Lu, PJ;Yen, CY;chang, JY
國家衛生研究院 2012-07-27 Hepatitis B virus X protein upregulates mTOR signaling through IKKBeta to increase cell proliferation and VEGF production in hepatocellular carcinoma Yen, CJ;Lin, YJ;Yen, CS;Tsai, HW;Tsai, TF;Chang, KY;Huang, WC;Lin, PW;Chiang, CW;Chang, TT
國家衛生研究院 2011-11-15 Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo Chang, KY;Tsai, SY;Wu, CM;Yen, CJ;Chuang, BF;Chang, JY
國家衛生研究院 2011-09-23 A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou Chang, KY;Yen, CJ;Hsieh, CY;Tsou, HH;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY
國家衛生研究院 2011-09 Phase II study of low-dose everolimus plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for first-line treatment of metastatic or recurrent gastric cancers Yeh, K;Shen, YC;Li, CP;Yen, CJ;Lin, YL;Lin, ZZ;Chen, LT;Su, WC;Chao, Y;Cheng, AL
國家衛生研究院 2011-07-01 A clustered ground-glass hepatocyte pattern represents a new prognostic marker for the recurrence of hepatocellular carcinoma after surgery Tsai, HW;Lin, YJ;Lin, PW;Wu, HC;Hsu, KH;Yen, CJ;Chan, SH;Huang, W;Su, IJ
國家衛生研究院 2011-06-23 Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells Chen, YJ;Huang, WC;Wei, YL;Hsu, SC;Yuan, P;Lin, HY;Wistuba, I;Lee, JJ;Yen, CJ;Su, WC;Chang, KY;Chang, WC;Chou, TC;Chou, CK;Tsai, CH;Hung, MC
國家衛生研究院 2010-10 A phase II study of weekly docetaxel and cisplatin plus oral tegafur/uracil and leucovorin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer Li, CP;Chen, JS;Chen, LT;Yen, CJ;Lee, KD;Su, WP;Lin, PC;Lu, CH;Tsai, HJ;Chao, Y
國家衛生研究院 2010-08 Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults Kuo, HK;Chen, CY;Liu, HM;Yen, CJ;Chang, KJ;Chang, CC;Yu, YH;Lin, LY;Hwang, JJ
國家衛生研究院 2010-02-09 ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway Kuo, HP;Lee, DF;Chen, CT;Liu, M;Chou, CK;Lee, HJ;Du, Y;Xie, XM;Wei, YK;Xia, WY;Zhang, WH;Yang, JY;Yen, CJ;Huang, TH;Tan, MJ;Xing, G;Zhao, YM;Lin, CH;Tsai, SF;Fidler, IJ;Hung, MC
國家衛生研究院 2009-05 Hepatitis B virus-X protein upregulates TSC1/m-TOR pathway and enhance angiogenesis in hepatitis B associated hepatocellular carcinoma Yen, CJ;Tsai, HW;Chang, KY;Cheng, CC;Lin, PW;Chang, TT;Chiang, CW
國立臺灣大學 2009-03 Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults Kuo, HK; Chen; CY; Liu, HM; Yen, CJ; Chang, KJ; Chang, CC; Yu, YH; Lin, LY; Hwang, JJ
國立臺灣大學 2007-11 Two Decades of Universal Hepatitis B Vaccination in Taiwan: Impact and Implication for Future Strategies. Ni, YH; Huang, LM; Chang, MH; Yen, CJ; Lu, CY; You, SL; Kao, JH; Lin, YC; Chen, HL; Hsu, HY; Chen, DS.
國家衛生研究院 2007-02-26 The role of the VEGF-C/VEGFR-3 axis in cancer progression Su, JL; Yen, CJ; Chen, PS; Chuang, SE; Hong, CC; Kuo, IH; Chen, HY; Hung, MC; Kuo, ML
國立臺灣大學 2007-02 The role of the VEGF-C/VEGFR-3 axis in cancer progression. Su JL; Yen CJ; Chen PS; Chuang SE; Hong CC; Kuo IH; Chen HY; Hung MC; Kuo ML
國立臺灣大學 2007 The Association between Abnormal Liver Function and Risk Factors of Metabolic Syndrome among Freshmen Tsai, PY; Yen, CJ; Li, YC; Chiu, TY; Chen, CY; Jan, CF
國立臺灣大學 2007 The Seroprevalence of Hepatitis B Viral Markers among Freshmen – 20 Years after Mass Hepatitis B Vaccination Program in Taiwan Chang, HC; Yen, CJ; Li, YC; Chiu, TY; Jan, CF
國立臺灣大學 2006-08 Exploring how peak leg power and usual gait speed are linked to late-life disability: data from the National Health and Nutrition Examination Survey (NHANES), 1999-2002 Kuo, HK; Leveille, SG; Yen, CJ; Chai, HM; Chang, CH; Yeh, YC; Yu, YH; Bean, JF

顯示項目 46-95 / 99 (共2頁)
1 2 > >>
每頁顯示[10|25|50]項目